Director and Former Interim Chief Executive Officer and President · Opus Genetics, Inc. (IRD)

Richard Rodgers

FY2023 is the first fiscal year CompBrief holds for Richard Rodgers as a named executive officer of Opus Genetics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$899,076

Salary $379,626Stock awards $419,450Bonus $100,000

4th of 6 named executive officers at Opus Genetics by FY2023 total.

6 named officers on file for Opus Genetics, FY2023

Richard Rodgers’s pay file — $29

  • 1 fiscal year of pay, line by line
  • IRD’s disclosed peer group of 10 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Opus Genetics’s whole pay program stands against its peers

  • Opus Genetics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A).

Free

Get Richard Rodgers’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Rodgers compensation by year

Opus Genetics Summary Compensation Table · the one fiscal year held
In US dollars, as Opus Genetics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023
Salary$379,626
Bonus$100,000
Stock awards$419,450
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$0
Total$899,076

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed April 29, 2024, accession 0001140361-24-023004, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-24-023004. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU50,000$150,500—
RSU35,000$105,350—

Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Opus Genetics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Mina SoochFormer Chief Executive Officer and President$2,811,138
George MagrathChief Executive Officer$2,667,353
Ronil PatelChief Business Officer$1,102,364
Richard Rodgers · this pageDirector and Former Interim Chief Executive Officer and President$899,076
Bernhard HoffmannSenior Vice President of Corporate Development$789,918
Amy RabournSenior Vice President of Finance$789,918

Board service

Opus Genetics board · FY2021–FY2025
Director compensation in US dollars, as Opus Genetics reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$63,813$75,529$50,108$0$189,450
FY2024$144,500$75,800$47,177$0$267,477
FY2022$62,000—$29,530—$91,530
FY2021$60,000—$87,301—$147,301

Each year as the company reported it in Opus Genetics's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Opus Genetics pays directors a $42,000 cash retainer and $120,000 in RSUs and Options. As stated in Opus Genetics's FY2025 proxy.

Committees

Audit (Chair)

The full Opus Genetics compensation record

free company brief

This page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Opus Genetics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Rodgers's compensation dossier · One-time report. No refunds.